Recruiting
Therapeutic Efficacy and Safety Evaluation of AI in the Management of Diabetes: A RCT Trial
NCT06957093
- Conditions
- Artificial Intelligence (AI), Diabetes Mellitus, Diabetes Mellitus Type 2 (T2DM), +5 more
- Locations
-
- The First Hospital of Jilin University Changchun, Jilin, China